PL1905775T3 - Związki tetracyliczne, sposób ich wytwarzania, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako ligandy receptorów dopaminergicznych - Google Patents

Związki tetracyliczne, sposób ich wytwarzania, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako ligandy receptorów dopaminergicznych

Info

Publication number
PL1905775T3
PL1905775T3 PL07291135T PL07291135T PL1905775T3 PL 1905775 T3 PL1905775 T3 PL 1905775T3 PL 07291135 T PL07291135 T PL 07291135T PL 07291135 T PL07291135 T PL 07291135T PL 1905775 T3 PL1905775 T3 PL 1905775T3
Authority
PL
Poland
Prior art keywords
preparing
pharmaceutical compositions
compositions containing
dopamine receptors
tetracyclic compounds
Prior art date
Application number
PL07291135T
Other languages
English (en)
Inventor
Jean-Louis Peglion
Christophe Poitevin
Mark Millan
Mauricette Brocco
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of PL1905775T3 publication Critical patent/PL1905775T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL07291135T 2006-09-26 2007-09-25 Związki tetracyliczne, sposób ich wytwarzania, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako ligandy receptorów dopaminergicznych PL1905775T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0608413A FR2906249B1 (fr) 2006-09-26 2006-09-26 Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP07291135A EP1905775B1 (fr) 2006-09-26 2007-09-25 Composés tétracycliques, leur procédé de préparation, les compositions pharmaceutiques qui les contiennent et leur utilisation comme ligands des récepteurs dopaminergiques.

Publications (1)

Publication Number Publication Date
PL1905775T3 true PL1905775T3 (pl) 2011-03-31

Family

ID=37877016

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07291135T PL1905775T3 (pl) 2006-09-26 2007-09-25 Związki tetracyliczne, sposób ich wytwarzania, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako ligandy receptorów dopaminergicznych

Country Status (32)

Country Link
US (1) US7470683B2 (pl)
EP (1) EP1905775B1 (pl)
JP (1) JP2008100995A (pl)
KR (1) KR100934315B1 (pl)
CN (1) CN101153043B (pl)
AR (1) AR062950A1 (pl)
AT (1) ATE480544T1 (pl)
AU (1) AU2007219281A1 (pl)
BR (1) BRPI0703655A2 (pl)
CA (1) CA2603274C (pl)
CY (1) CY1110799T1 (pl)
DE (1) DE602007009004D1 (pl)
DK (1) DK1905775T3 (pl)
EA (1) EA013406B1 (pl)
ES (1) ES2351945T3 (pl)
FR (1) FR2906249B1 (pl)
GE (1) GEP20104877B (pl)
HK (1) HK1119163A1 (pl)
HR (1) HRP20100605T1 (pl)
MA (1) MA29371B1 (pl)
MX (1) MX2007011524A (pl)
MY (1) MY142517A (pl)
NO (1) NO20074889L (pl)
NZ (1) NZ561905A (pl)
PL (1) PL1905775T3 (pl)
PT (1) PT1905775E (pl)
RS (1) RS51418B (pl)
SG (1) SG141382A1 (pl)
SI (1) SI1905775T1 (pl)
UA (1) UA96125C2 (pl)
WO (1) WO2008037888A2 (pl)
ZA (1) ZA200708215B (pl)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
FR2721027B1 (fr) 1994-06-08 1996-07-19 Adir Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant.
FR2741074B1 (fr) 1995-11-09 1997-12-19 Adir Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2767825A1 (fr) * 1997-09-01 1999-02-26 Adir Nouvelles trans-3,4,4a,5,6,10b-hexahydro-2h-napht°1,2-b!-1, 4-oxazines disubstituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2845994B1 (fr) * 2002-10-18 2006-05-19 Servier Lab Nouveaux derives de benzo[e][1,4]oxazino[3,2-g]isoindole substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
AU2007219281A1 (en) 2008-04-10
KR100934315B1 (ko) 2009-12-29
WO2008037888A2 (fr) 2008-04-03
CY1110799T1 (el) 2015-06-10
CN101153043B (zh) 2011-01-19
EP1905775B1 (fr) 2010-09-08
US7470683B2 (en) 2008-12-30
NO20074889L (no) 2008-03-27
NZ561905A (en) 2009-01-31
MA29371B1 (fr) 2008-04-01
RS51418B (en) 2011-02-28
GEP20104877B (en) 2010-01-11
EP1905775A1 (fr) 2008-04-02
ATE480544T1 (de) 2010-09-15
BRPI0703655A2 (pt) 2009-05-19
KR20080028316A (ko) 2008-03-31
DE602007009004D1 (de) 2010-10-21
CA2603274C (fr) 2010-08-31
SI1905775T1 (sl) 2010-10-29
CA2603274A1 (fr) 2008-03-26
MY142517A (en) 2010-12-15
ZA200708215B (en) 2008-09-25
SG141382A1 (en) 2008-04-28
UA96125C2 (ru) 2011-10-10
AR062950A1 (es) 2008-12-17
EA013406B1 (ru) 2010-04-30
CN101153043A (zh) 2008-04-02
WO2008037888A3 (fr) 2008-06-12
EA200701807A1 (ru) 2008-04-28
HK1119163A1 (en) 2009-02-27
US20080076765A1 (en) 2008-03-27
MX2007011524A (es) 2009-02-16
PT1905775E (pt) 2010-11-17
HRP20100605T1 (hr) 2010-12-31
JP2008100995A (ja) 2008-05-01
FR2906249A1 (fr) 2008-03-28
ES2351945T3 (es) 2011-02-14
FR2906249B1 (fr) 2008-12-19
DK1905775T3 (da) 2010-12-06

Similar Documents

Publication Publication Date Title
IL196280A0 (en) Use of ampk-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them
IL200854A (en) Converted Spiro Compounds, Methods for their Preparation and Pharmaceutical Compositions Containing Them to Delay New Vascular Formation
EP2184064A4 (en) 5-HT6 RECEPTOR LIGAND, PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURE AND USE
IL203142A (en) Anti-B antibody CD79, pharmaceuticals including them, their use and method of preparation
AP2975A (en) Pharmaceutical formulations containing dopamine receptor ligands
HK1148272A1 (en) 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor 3-
HK1144784A1 (en) Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine recptor ligands
HUP0600809A2 (en) New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
MY144726A (en) Diosmetin compounds, process for their preparation and pharmaceutical compositions containing them
SI1953161T1 (sl) Novi tricikliäśni derivati, postopek priprave le-teh in farmacevtski sestavki, ki jih vsebujejo
IL207356A0 (en) 5, 6 - bisaryl-2- pyridine - carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors
HUP0600808A2 (en) New benzamide derivatives as bradykinin antagonists, process for their preparation and pharmaceutical compositions containing them
IL218525A (en) Compounds 2,1 - Dihydro - 2 - Oxoquinoline Receptor Legendants 5 - 4ht Process for Preparing, Containing and Using Medical Preparations
HUP0700269A2 (en) Pyrimidinyl-piperazines useful as d3/d2 receptor ligands, pharmaceutical compositions containing them and their use
EP2285215A4 (en) NOVEL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREFOR AND METHOD OF USE THEREOF
IL198634A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
PT1873140E (pt) Novos derivados naftalénicos, processo para a sua preparação e composições farmacêuticas que os contenham
SI2147915T1 (sl) Novi cikloalkilirani benzotiadiazinski derivati postopek za njihovo pripravo in farmacevtski sestavki ki jih vsebujejo
PL1905775T3 (pl) Związki tetracyliczne, sposób ich wytwarzania, zawierające je kompozycje farmaceutyczne i ich zastosowanie jako ligandy receptorów dopaminergicznych
EP2366684A4 (en) NOVEL COMPOUND OF THE PTÉROCARPAQUINONES FAMILY, PROCESS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING THESE NOVEL COMPOUNDS OF THE PTÉROCARPAQUINONES FAMILY, USES AND THERAPEUTIC METHOD
HUP0600847A3 (en) Chiral betha aminoacids and their derivatives, process for their preparation pharmaceutical compositions containing the same and use of the compounds